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The purpose of the study was to condense existing scientific evidence about the relation between aluminum
(Al) exposure and risk for the development of Alzheimer’s Disease (AD), evaluating its long-term effects on the
population’s health. A systematic literature review was carried out in two databases, MEDLINE and LILACS, between
1990 and 2005, using the uniterms: “Aluminum exposure and Alzheimer Disease” and “Aluminum and risk for
Alzheimer Disease”. After application of the Relevance Test, 34 studies were selected, among which 68% established
a relation between Al and AD, 23.5% were inconclusive and 8.5% did not establish a relation between Al and AD.
Results showed that Al is associated to several neurophysiologic processes that are responsible for the characteristic
degeneration of AD. In spite of existing polemics all over the world about the role of Al as a risk factor for AD, in
recent years, scientific evidence has demonstrated that Al is associated with the development of AD.
DESCRIPTORS: Alzheimer disease; aluminum; risk factors
ALUMINIO COMO FACTOR DE RIESGO PARA LA ENFERMEDAD DE ALZHEIMER
El objetivo del estudio fue condensar la evidencia científica existente entre la exposición al aluminio
(Al) y el riesgo para el desarrollo de la Enfermedad de Alzheimer (EA), evaluando los efectos para la salud de
la población a largo plazo. Una revisión sistemática de la literatura científica existente entre 1990 y 2005, fue
realizada en dos bases de datos, MEDLINE y LILACS, utilizando los unitermos: “Aluminium exposure and
Alzheimer Disease” y “Aluminium and risk for Alzheimer Disease”. Fueron seleccionados 34 trabajos para la
investigación, de los cuales 68% establecieron relação entre el Al y la EA, 23,5% no presentaron datos conclusivos
y 8,5% no establecieron ninguna relación entre el Al y la EA. A partir de los resultados obtenidos, se verifica
que el Al interviene en diversos procesos neurofisiológicos responsables por la degeneración característica de
la EA. A pesar de la polémica existente en el médio científico, la evidencia científica demuestra a lo largo de los
últimos años que el Al es uno de los determinantes para el desenvolvimiento de la EA.
DESCRIPTORES: enfermedad de Alzheimer; alumínio; factores de riesgo
ALUMÍNIO COMO FATOR DE RISCO PARA A DOENÇA DE ALZHEIMER
O objetivo do estudo foi condensar a evidência científica existente entre a exposição ao alumínio (Al)
e risco para o desenvolvimento da doença de Alzheimer (DA), avaliando os efeitos para saúde da população,
a longo prazo. Realizou-se revisão sistemática de literatura produzida entre 1990 e 2005, conduzida em duas
bases de dados, MEDLINE e LILACS, utilizando os unitermos: “Aluminium exposure and Alzheimer Disease” e
“Aluminium and risk for Alzheimer Disease”. Foram selecionados 34 trabalhos para a pesquisa, desses, 68%
estabeleceram relação entre o Al e a DA, 23,5% não apresentaram dados conclusivos e 8,5% não estabeleceram
nenhuma relação entre o Al e DA. A partir dos resultados obtidos, verifica-se que o Al intervém em diversos
processos neurofisiológicos responsáveis pela degeneração característica da DA. Apesar da polêmica existente,
a evidência científica demonstra, ao longo dos últimos anos, que o Al se associa com o desenvolvimento da DA.
DESCRITORES: doença de Alzheimer; alumínio; fatores de risco
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INTRODUCTION
Aluminum (Al) is a common metal in the
environment and one of the most abundant in the
terrestrial crust. Al is liberated in the environment by
natural processes of soil erosion, volcanic eruptions
and anthropogenic actions. Bauxite is the most
important source, containing 55% of Al oxide.
The larger portion of Al ingestion is provided
through food in different ways: food contaminated by
Al, water, and industrialized food that contains Al as
conservant and/or colorant.
Even though food is an important source of
Al ingestion, it is water which presents a higher
bioavailability to be absorbed by the intestine(1). Al
salts are largely used as coagulants to reduce organic
matter, turbidness and microorganisms present during
treatment of superficial water, which presents the
largest quantity of particles in suspension. This use,
although useful for water treatment in many cities,
can increase the concentration of Al at the final point
of consumption(2).
Some studies appoint the presence of Al in
potable water and in food as one of the etiological
agents of mental diseases. There is also a hypothesis
that exposure to this element represents a risk for
the development of Alzheimer’s disease(1).
In 1965, an intracerebral inoculation of Al
phosphate in rabbits was reported. It resulted in
neurofibrilar degeneration significantly similar to the
neurofibrilar degeneration of Alzheimer’s Disease
(AD), which led to the assumption that there is a
relation between Al and AD. In 1973, the first article
that evidenced increase in Al concentration in patients
with AD was published(3).
AD is a neurodegenerative disorder prevalent
in the senile population. It is clinically characterized
by the progressive loss of memory and other cognitive
abilities and pathologically by severe neuronal loss,
glial proliferation and amyloid plaques composed of
β-amyloid protein (Aβ) surrounded by degenerated
nervous terminations and neurofibrilar tangles(4). This
pathology is diagnosed when other dementia causes
are excluded, because only necropsy permits the
establishment of a definitive AD diagnosis(5).
AD is probably the result of a multifactorial
process in which genetic and environmental
components are included. It is supposed that individual
genetic characteristics modulate environmental
exposures. Environmental risk factors related to the
development of AD include exposition to Al, one of
the most studied potential environmental risk factors.
AD has also being related with other risk factors, such
as the chemical risk related to the reduction of
neurotransmitters, which would be responsible for
intellectual and behavioral performance in brains of
patients with AD(6).
Another risk factor is the Apolipoprotein E
susceptibility gene, which is related to AD(5). Some
researchers believe that alterations in aging neurons
can lead to a self-immune answer, giving origin to AD(6).
There is also a hypothesis of association with
alterations in the hematoencephalic barrier and with
severe brain injury, which lead to a loss of conscience
and eventual development of AD(6). Age and a family
history of dementia appear as the most important
risk factors in the disease etiology.
Considering that there is a natural loss of
immune answer capacity during the aging process, the
development of pathologies is most frequent and most
severe in aged persons. In addition, there are extrinsic
factors, life style, socioeconomic condition and
psychosocial and environmental factors determining
functional, cellular and molecular alterations, which lead
to diminished homeostatic balance and, consequently,
greater predisposition to diseases(7).
Demographic and epidemiological data
indicate population aging all over the world. It is
estimated that the number of people affected by AD
in the world will surpass 26 million; in Brazil, estimates
refer to around 500 thousand people. The disease
prevalence ranges from 1.4% of individuals between
65 and 69 years old to 20.8% of those between 85
and 89 years old, reaching approximately 38.6% of
those between 90 and 95 years old(7). AD represents
70% of the set of diseases that affect the geriatric
population.
This article condensed existing scientific
evidence of the relation between Al exposure and the
risk of development of AD from research results
published between 1990 and 2005, using a
reproducible bibliographic review technique called
Systematic Literature Review.
METODOLOGY
The systematic literature review was
conducted according to a sequence of steps described
in Figure 1.
Aluminum as a risk factor...
Ferreira PC, Piai KA, Takayanagui AMM, Segura-Muñoz SI
Rev Latino-am Enfermagem 2008 janeiro-fevereiro; 16(1):151-7
www.eerp.usp.br/rlae
153
The relation between exposure to Al and the
risk of developing AD was the focus of this study. The
literature search was conducted in publications
between 1990 and 2005, in two databases, MEDLINE
and LILACS. The articles were identified through the
uniterms: Aluminum Exposure and Alzheimer Disease,
and Aluminum and Risk for Alzheimer Disease.
The criteria defined in the Relevance Test
were used for the selection of studies. Only studies
that positively answered all inclusion criteria
participated in the Systematic Literature Review.
These criteria are: a) Is the study about AD and/or Al
toxicity? ; b) Does it address potential etiological
agents or risk factors for development of AD?; c) Was
it published between January 1990 and December
2005?; d) Was it published in English, Spanish,
Portuguese or French?
The search in the databases and application
of the Relevance Test, both to abstracts as to full texts,
were carried out by two researchers independently,
aiming to assure method objectivity. The Relevance
Test was applied twice. It was first applied to the
abstracts and, then, the articles that would participate
preliminarily in the study were selected(8). After that,
all full articles were collected for the application of
the second Relevance Test. After the study was
completely read, its inclusion or exclusion in the study
was confirmed. In view of divergences regarding the
inclusion or exclusion of some studies, a third
researcher was consulted, according to
recommendations by the Cochrane Foundation.
Bibliographic, editorial reviews, or communications
were not included in the Systematic Literature Review.
Once the full texts had been selected, the
information was analyzed and organized in synoptic
charts, presenting the bibliographic reference. Thus,
the existing experimental evidence on the relation
between exposure to Al and the risk of developing
AD was condensed from the results of this study.
RESULTS
In this search, 174 studies related with the
theme were obtained. After the application of the
Relevance Test, 69 studies were selected and 16 were
excluded because they included no abstracts, 40 did
not affirmatively answer all questions of the Relevance
Test, 43 were review articles and 6 were comments.
From the 69 studies selected through the first
application of the Relevance Test, 46 full texts were
obtained.
The 46 full texts were reviewed and analyzed,
aiming to identify the type of relation between Al and
AD. After the second application of the Relevance Test,
34 studies were selected and 12 articles were excluded:
two were comments, six did not affirmatively answer
all questions of the Relevance Test and four were
reviews. Of the 34 articles selected for the study, 68%
(23 studies) established a relation between Al and AD,
23.5% (8 studies) did not present conclusive data and
8.5% (three studies) did not establish any relation
between Al and AD. Table 1 shows studies that did not
present conclusive data or did not establish a relation
between Al and AD and Table 2 presents articles that
established a relation between Al and AD.
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Figure 1 - Flow chart for the conduction of a Systematic Literature Review(8).
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Table 1 - Studies that did not present conclusive data or did not establish any relation between Al and AD
Table 2 - Studies that presented a relation between exposure to Al and AD
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DISCUSSION
Despite the epidemiological, social, and
economic importance of AD in the world, this study
evidenced that few studies have been published on
this topic in Latin America. Almost all selected studies
originated in Europe, the United States, Canada or
Asia; only one of the selected studies is from Latin
America, specifically from Brazil.
According to the Systematic Literature
Review, AD is associated with a general reduction of
cerebral tissue, with localized loss of neurons, mainly
in the hypofield and basal forebrain. An experimental
study performed with mice treated with Al
demonstrated a statistically significant reduction in
their brain weight(9). Two microscopic aspects are
typical in AD, the extra cellular amyloid plaques, also
called senile plaques, which consist of extra cellular
deposits of Aβ protein, and neurofibrilar intraneuron
tangles that consist of filaments of a fosforilated form
of a protein associated to microtubes (Tau). Alteration
in the processing of the Aβ protein from its precursor,
APP (amyloid precursor protein), is recognized as an
essential characteristic in the AD pathogeny(10).
There are two types of Aβ protein, Aβ40 and
the Aβ42. The Aβ40 protein is normally produced in
small quantities, though the Aβ42 presents a super
production due genetic mutations. Both proteins
aggregate to form amyloid plaques. However, the
Aβ42 presents a higher tendency to do this than Aβ40,
constituting the main responsible in the formation of
amyloid plaques. The Aβ40 and Aβ42 are produced
by proteolytic cleavage of a precursor amyloid protein,
the APP, a protein of larger membrane and normally
expressed by many cells, including neurons of the
central nervous system(10). The APP mutations of
genes ease the formation of Aβ, especially the Aβ-42
(Figure 2), with consequent increase in the formation
of amyloid plaques(10). It has been observed that Al
increases the Aβ protein neurotoxicity, the
degeneration of neurons exposed to it and also
aggregation of Aβ protein(11).
Figure 2 - Adapted diagram of APP processing. The physiological route originates the APP; mutation in the APP
originates Aβ, aggregation is favored by mutation in the ApoE4 gene. Triggering of neurofibrilar tangles formation
and processes of neuronal death; AD manifestations(10).
Tau protein becomes abnormally fosforilated
in AD and is deposited intracellulary under the form of
paired helical filaments with a characteristic
microscopical aspect. When the cell dies, these filaments
aggregate as neurofibrilar extracellular tangles. There
is a strong influence of Al ions on fosforilation which can
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be the cause, because neurofibrilar tangles contain
hyperfosfolated microtubules associated to the Tau
protein. It is possible that the Tau fosforilation is
intensified by the existence of myloid plaques. Its
fosforilation compromises rapid axonal transport, a
process that depends on the microtubule(10).
The increased concentration of Al favors the
formation of Tau protein and, consequently, the formation
of neurofibilar tangles(12). It was discovered in a previous
study that the amyloid plaques are surrounded by glial
reactive cells, Thus, exposition to Al can activate the
oxidative processes of glial cells, which in turn can
indirectly damage the neurons integrity(13).
The neuron degeneration observed in AD can
also occur due to oxidative stress. Oxidative stress
refers to conditions like as hypoxia, characterized by
compromised protection mechanisms, as the neurons
become more susceptible to excitotoxic lesion.
Oxidative stress is induced in brains exposed to Al(10).
It was demonstrated in an epidemiological
study that individuals who used to ingest food with
high Al contents presented a two times higher risk of
developing AD(14).
Studies show that mice with prolonged
exposure to Al soluble salt can develop AD, with
selective loss of neurons and the cholinergic function.
Al also diminishes the transmission of acetylcholine
and attenuates its release, causing reduction of reflexes.
Al appears as a reductor of neuronal activity, showing
similarity with the decreased cholinergic action in AD.
Al leads to behavioral alterations only in old rabbits,
not in the young ones. Thus, mature brains are more
susceptible to Al toxicity than immature ones(15).
FINAL CONSIDERATIONS
Results show that 68% of the analyzed
studies present Al as one of the risk factors for AD,
confirming and describing the toxicological
mechanisms through which Al affects the nervous
tissue.
In this study, the need to understand the
importance of environmental factors is highlighted,
especially exposure to Al, as determinants in the
population’s health-disease process, stressing its
potential to affect, positively or negatively, natural
aging processes.
It was verified through a general evaluation
of studies that, according to an important group of
researchers, Al affects several neurophysiological
processes, responsible for the degeneration
characteristic of AD. Therefore, scientific evidence has
shown that, in the last years, Al has been associated
with the development of AD. Thus, preventing
exposure to certain environmental factors like Al,
among others, could diminish the incidence of chronic-
degenerating diseases like AD, which in recent years
has acquired great importance for collective health
all over the world.
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